Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.07)
# 444
Out of 4,842 analysts
83
Total ratings
34.15%
Success rate
21.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $1.88 | +113.20% | 9 | May 19, 2025 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.84 | +19.05% | 13 | May 15, 2025 | |
| VSTM Verastem | Maintains: Buy | $10 → $14 | $7.61 | +83.97% | 14 | May 9, 2025 | |
| DWTX Dogwood Therapeutics | Upgrades: Buy | $10 | $5.60 | +78.57% | 1 | Apr 23, 2025 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $12.44 | +60.77% | 12 | Apr 14, 2025 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $40 | $32.46 | +23.23% | 10 | Apr 1, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $8 → $5.5 | $0.27 | +1,914.65% | 11 | Mar 28, 2025 | |
| CRVS Corvus Pharmaceuticals | Reiterates: Buy | $11 | $3.78 | +191.01% | 3 | Mar 26, 2025 | |
| MYO Myomo | Maintains: Buy | $7.5 → $9.5 | $3.07 | +209.45% | 5 | Mar 12, 2025 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $100 | $3.56 | +2,708.99% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.27 | +2,262.20% | 1 | Dec 5, 2022 |
CASI Pharmaceuticals
May 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.88
Upside: +113.20%
Cytosorbents
May 15, 2025
Reiterates: Neutral
Price Target: $1
Current: $0.84
Upside: +19.05%
Verastem
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $7.61
Upside: +83.97%
Dogwood Therapeutics
Apr 23, 2025
Upgrades: Buy
Price Target: $10
Current: $5.60
Upside: +78.57%
Alphatec Holdings
Apr 14, 2025
Reiterates: Buy
Price Target: $20
Current: $12.44
Upside: +60.77%
Monopar Therapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $32.46
Upside: +23.23%
Plus Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $8 → $5.5
Current: $0.27
Upside: +1,914.65%
Corvus Pharmaceuticals
Mar 26, 2025
Reiterates: Buy
Price Target: $11
Current: $3.78
Upside: +191.01%
Myomo
Mar 12, 2025
Maintains: Buy
Price Target: $7.5 → $9.5
Current: $3.07
Upside: +209.45%
Kazia Therapeutics
Jul 12, 2024
Reiterates: Buy
Price Target: $100
Current: $3.56
Upside: +2,708.99%
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.27
Upside: +2,262.20%